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Abstract
Background: The revolutionary concept of “jumping genes” was conceived by McClintock in the late 1940s while
studying the Activator/Dissociation (Ac/Ds) system in maize. Transposable elements (TEs) represent the most abundant
component of many eukaryotic genomes. Mobile elements are a driving force of eukaryotic genome evolution.
McClintock’s Ac, the autonomous element of the Ac/Ds system, together with hobo from Drosophila and Tam3 from
snapdragon define an ancient and diverse DNA transposon superfamily named hAT. Other members of the hAT
superfamily include the insect element Hermes and Tol2 from medaka. In recent years, genetic tools derived from the
‘cut’ and ‘paste’ Tol2 DNA transposon have been widely used for genomic manipulation in zebrafish, mammals and in
cells in vitro.
Results: We report the purification of a functional recombinant Tol2 protein from E.coli. We demonstrate here that
following microinjection using a zebrafish embryo test system, purified Tol2 transposase protein readily catalyzes gene
transfer in both somatic and germline tissues in vivo. We show that purified Tol2 transposase can promote both in vitro
cutting and pasting in a defined system lacking other cellular factors. Notably, our analysis of Tol2 transposition in vitro
reveals that the target site preference observed for Tol2 in complex host genomes is maintained using a simpler target
plasmid test system, indicating that the primary sequence might encode intrinsic cues for transposon integration.
Conclusions: This active Tol2 protein is an important new tool for diverse applications including gene discovery and
molecular medicine, as well as for the biochemical analysis of transposition and regulation of hAT transposon/genome
interactions. The measurable but comparatively modest insertion site selection bias noted for Tol2 is largely determined
by the primary sequence encoded in the target sequence as assessed through studying Tol2 protein-mediated
transposition in a cell-free system.
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Background
Our understanding of transposable elements (TEs)
begins with McClintock’s revolutionary work with the
Activator/Dissociation (Ac/Ds) system in maize [1]. Ac,
the autonomous element of the Ac/Ds system, together
with hobo from Drosophila and Tam3 from snapdragon
define an ancient and diverse DNA transposon super-
family named hAT [2–4]. Widespread in plants and
animals, hAT transposons are the most abundant DNA
transposons in humans [5]. However, none of the human
hAT elements have been active during the past 50 million
years [5].
The first active DNA transposon discovered in verte-
brates was the medaka fish (Oryzias latipes)-derived
hAT element Tol2 [6]. Tol2 shares a number of features
with other hAT members including transposases with a
DDE (aspartate-aspartate-glutamate) catalytic motif,
short terminal inverted repeats (TIRs) and formation of
8-bp host duplications upon transposition [2, 7]. Because* Correspondence: ekker.stephen@mayo.edu1Department of Biochemistry and Molecular Biology, Mayo Clinic, 200 1st St
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derivatives from Tol2 have high cargo-capacity and low
susceptibility to over-production inhibition, they have
become popular gene transfer agents in a variety of ani-
mal systems, including zebrafish, African frog, chicken,
mouse and human cell cultures including primary T cells
[8], and for various genome biology applications (for
reviews, see [9, 10].
TEs generally display very diverse patterns of target
site selectivity. Studying the mechanisms for such
selection is useful to gain insights on the biology of
transposition, shedding light on the genome structure
and designing better transposon tools for specific appli-
cations. Previous research has suggested that the mecha-
nisms of target site selection are very complex and
varied from mobile element to mobile element. In many
cases, it involves the direct interaction between the
transposase/recombinase and the target DNA or their
indirect communication through accessory proteins [11].
However, specific factors that contribute to hAT element
integration preference are largely unknown.
Our knowledge of transposition is largely based on
bacterial TEs. Less is known about eukaryotic transpo-
sase proteins since they have been historically more diffi-
cult to express and reconstitute in vitro. In the present
work, we establish a recombinant Tol2 protein-based
system to serve as a tool for genome engineering and to
probe the transposition mechanism of this vertebrate
hAT transposon, focusing on the integration steps. We
directly compare known Tol2 isoforms for activity in
both human cells and zebrafish in vivo. We demonstrate
that the highest activity variant can be epitope-tagged
and retain full activity, and we purify epitope-tagged
Tol2 protein (His-Tol2) from E. coli. The functionality of
this recombinant Tol2 transposase is demonstrated in
vivo in zebrafish using both somatic and germline trans-
position assays. Thus His-Tol2 protein is a viable new
source of transposase for molecular medicine and gen-
ome engineering applications.
We further show that purified His-Tol2 can carry out
both the excision and integration steps of transposition in
vitro in the absence of any cellular co-factors. Tol2 dis-
plays a modest preference for AT-rich DNA in vivo [12].
Such insertion bias is also noted in a cell-free and defined
assay when the insertion distribution of miniTol2 into a
target plasmid was measured. miniTol2 contains the
transposon end sequences necessary and sufficient in vivo
for excision and integration [13, 14]. miniTol2 inser-
tion is accompanied by 8-bp target site duplications
as occurs in vivo and displays an insertion site prefer-
ence in vitro, with a higher likelihood of insertion
into AT-rich sequences similar to that noted for in
vivo integrations [12]. These results suggest the target
selection mechanism is at least in part maintained in
this much simpler system.
Results
The 649 amino acid Tol2 isoform is the most active
transposase in vivo and in vitro
Different coding sequences and activities have been
described in previous works for the hAT transposase
Tol2. Two distinct endogenous Tol2 mRNAs were iden-
tified in the original medaka fish isolate [15]. The shorter
mRNA (Tol2-S, GenBank accession number AB031080)
is encoded by exons 2–4 and results in a predicted pro-
tein of 576 amino acids [15] (Fig. 1a). The longer Tol2
mRNA (Tol2-L, GenBank accession number AB031079)
is encoded by exons 1–4, and a protein of 685 amino
acids is predicted using the first in-frame start codon
[15] (Fig. 1a). Tol2-S inhibits excision by the Tol2-L
protein, this inhibition was probably not through com-
petition of DNA-binding but some other unknown
mechanism, as Tol2-S protein lacks the majority of the
BED zinc finger motif [16] (Fig. 1a). This also suggests
that the sequences encoded by exon 1 are critical to
Tol2 transposase function. When a copy of medaka Tol2
genomic sequence was introduced into zebrafish cells
that do not harbor any endogenous Tol2 elements, a
third Tol2 isoform of different length was identified
(Tol2-M) [17] (Fig. 1a). This mRNA encodes a pre-
dicted protein of 649 amino acids that is shorter at
the N-terminus than Tol2-L (Fig. 1a). This latter, heterol-
ogous mRNA (Tol2-M) is used in nearly all currently
available Tol2-based genetic tools [13, 18–20]. The activity
of the naturally occurring Tol2-L has not been explored in
detail or compared to Tol2-M under similar conditions.
To determine whether the isoforms of Tol2 might en-
code different functional outcomes, we compared Tol2
isoforms in human HeLa cell transposition assays upon
co-transfection of transposase helper and transposon
donor plasmids [13]. For Tol2-M, the gene-transfer activ-
ity is positively related to the amount of Tol2 transposase
provided as plasmids (Fig. 1c). In addition, through codon
optimization [21], we increased gene transfer in HeLa cells
by ‘humanizing’ the Tol2-M codon usage (hTol2-M). The
same strategy was applied to Tol2-L. However, even this
‘humanized’ Tol2-L (hTol2-L) showed reduced activity
compared to Tol2-M in human cells (Fig. 1c). Tol2-M also
showed higher activity than Tol2-L in zebrafish transpos-
ition assays [13] (data not shown). Thus the 649 amino
acid Tol2-M isoform shows the highest activity of the
three described protein forms (Fig. 1a), and will be re-
ferred to hereafter as Tol2 unless otherwise stated.
Tol2 can be modified on either the N- or C- terminus by
6XHis and retain full activity
The ability to identify and readily purify a protein is crit-
ical for the development of a system for biochemical
analysis. Targeted modification of vertebrate transposase
enzymes has been a challenge in the field. The addition
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Fig. 1 The highest activity Tol2 isoform and its modification by 6X His tag. a Tol2 genomic DNA (GenBank: D84375.2) structure and expressed mRNA
from various sources (Tol2-S GenBank: AB031080; Tol2-L GenBank: AB031079; Tol2-M GenBank: AB032244). The first nucleotide location is numbered in
relation to genomic DNA sequence in each mRNA and indicated by an open-ended arrow. The start and stop codons of the longest open reading
frame in each mRNA are also indicated. Tol2-L spans all 4 exons (black bar, E1-4) while Tol2-S covers only the last three (E2-4). Tol2-M starts further into
exon 1 than L. The predicted Tol2-M protein is slightly shorter at the amino-terminus than Tol2-L. Corresponding sequences encoding the BED zinc
finger DNA binding motif are indicated on genomic DNA and mRNA. b In this paper we used a modified Tol2-M mRNA [13] encoding the same
protein as Tol2-M, but all the nucleotides 5′ to the first start codon in Tol2-M (Fig. 1a, Tol2-M gray box) were deliberately removed to eliminate any
possible effects from an out-of-frame ATG within those sequences. 6X His tags were added to either 5′- or 3′ of the modified mRNA, and the deduced
N-terminus or C-terminus modified Tol2 protein sequences were outlined. c Human codon-optimized Tol2-M was most effective for gene transfer in
HeLa cells. Tol2-M was tested for activity in human cell culture by colony forming assay. A Tol2 transposon vector carrying a Zeocin resistance gene
cassette was co-transfected with different version of Tol2 or GFP control driven by CMV promoter at 50 ng or 500 ng. The numbers of Zeocin-resistant
colonies formed in each treatment were compared to the treatment with the highest colony numbers (500 ng CMV-hTo2-M) as percentages. Bars
represent mean values ± SEM of three independent experiments. * or ** indicate data is significantly different from respective CMV-GFP controls (* t-test
P< 0.05; ** t-test P< 0.01). d Tol2 transposase could be modified by 6XHis epitope without loss of activity. A GFP-reporter [13] was co-injected with
synthesized mRNA corresponding to untagged Tol2 or Tol2 tagged with 6X-His at either N-terminus (His-Tol2) or C-terminus (Tol2-His). Somatic GFP
expression was scored at 3 dpf and the percentages of injected fish demonstrating GFP only in the body (body only) or demonstrating strong GFP in
eyes and anywhere in the body (body + eyes) were recorded
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of new sequences normally results in either reduced or
limited enzymatic activity, as was the case for Sleeping
Beauty, the most studied vertebrate transposable elem-
ent [22, 23] or with Tol2 in prior studies [24, 25]. Here
we chose a small 6X-His protein tag for use with Tol2
(Fig. 1b).
To test if such modification will compromise transpo-
sase activity, zebrafish embryos were injected with syn-
thetic Tol2 transposase mRNA encoding Tol2, 5′-His
(6X) tagged Tol2, or 3′-His (6X) tagged Tol2 as well as
with a transposon reporter vector [13]. Embryos were
scored for GFP-positive cells or eyes with green fluores-
cence at 3 days post-fertilization (dpf) as described [13].
Visualization of net gene transfer into the eyes of
injected zebrafish embryos is a convenient and robust
assay system for determining Tol2-mediated transpos-
ition in somatic tissues [13]. Importantly, the 6X-His
tagged versions of Tol2 showed the same activity as the
untagged Tol2 proteins in this in vivo transposition assay
(Fig. 1d).
Purified His-Tol2 from E.coli
We examined the expression of both N- and C-terminally
tagged Tol2 variants in E. coli. The C-terminally tagged
version gave predominantly the full-length form with
multiple, smaller protein products. In contrast, the amino-
terminally tagged Tol2 (Fig. 2a) yielded a single protein
product at the predicted size (~74 kD) when purified from
E. coli (Fig. 2b, c). This His-Tol2 protein was used in all
subsequent studies unless noted otherwise.
Recombinant Tol2 protein is a fully functional hAT
transposase in vivo
Transposon tools are often used as a two-component
system in gene discovery and gene delivery applications
(Fig. 3a). One component is donor DNA containing a
genetic cargo of interest flanked by transposon terminal
sequences, and the other component is a transposase
source. In previously described vertebrate applications,
transposase was provided by either a DNA-encoding
plasmid or in vitro transcribed transposase-encoding
A
B C
Fig. 2 Expression and detection of recombinant Tol2 transposase protein. a Tol2 transpoase sequence was cloned into an N-terminal 6XHis expression
vector pET-21a (Novagen). The expression cassette driven by T7 promoter is shown, and a fusion protein of ~74 kD was expected. rbs: ribosome
binding site. b Expression of His-Tol2 in E.coli BL21-AI strain. unind: cell lysate from uninduced cells harboring Tol2-expression vector; t: total induced
crude cell lysate; i: insoluble protein fraction from induced cell lysate; s: soluble protein fraction from induced cell lysate. Equal volume of cell culture
was loaded in each lane. p: ~ 350 ng purified His-Tol2 protein (arrow head). c Immunoblot analysis of His-Tol2 expression with anti-His antibody. The
same protein samples as in (b) were loaded except that only ~ 6 ng purified His-Tol2 was used for detection by western blot
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mRNA. To determine if purified recombinant His-Tol2
protein is fully functional and robust enough to be an
alternative transposase source for practical genetic appli-
cations, we tested His-Tol2 function in vivo using this
two-component system in both somatic and germline
gene transfer assays.
For gene transfer testing in somatic cells, we used a
high stringency transposition test system in which inser-
tions of a specialized miniTol2 element, GBT-RP2 [26],
in transcriptionally competent genomic loci result in
enhanced Green Fluorescent Protein (GFP) expression in
the resulting animals. The GBT-RP2 element was based
on the 3′ gene trap derived from previously described
gene-breaking transposon (GBT) vectors [27, 28]. Trans-
poson DNA was co-injected with either Tol2 mRNA or
His-Tol2 protein into one-cell zebrafish embryos (Fig. 3a).
The F0 somatic GFP patterns of injected embryos gener-
ally can be characterized into different categories based on
signal uniformity at 3 days post-fertilization (dpf): a cat-
egory I pattern is characterized by embryos showing
A B
C D
Fig. 3 His-Tol2 is a fully functional transposase in vivo. a Diagram showing microinjection of zebrafish embryo at one-cell stage to generate transgenic
animals. GBT-RP2 plasmid containing GFP-reporter gene trap was co-injected with either Tol2 mRNA or His-Tol2 protein. Mosaic somatic GFP signals
were seen in F0 injected fish. F0 embryos were raised to adult and outcrossed to obtain F1 generation. Ubiquitous GFP would be detected in F1 fish if
the integration was due to a gene trap event and was passed through the germline. Molecular analysis of transposon insertion numbers and genomic
locations was carried out on tissue from F1 generation animals. Pβ-actin: β-actin promoter; SD: splice donor. b Representative images of F0 embryos
demonstrating a catalog of GFP-positive somatic patterns that could be observed at 3 dpf from microinjections of different methods. Notice the signal
difference in eyes (double arrow) and brain regions (open end arrow) for each category. With vector-only injections, notice only Cat. I and II patterns
were observed. c A small number of His-Tol2 protein injected embryos showing ubiquitous whole body green fluorescence as early as 24 hpf. Those
fish generally displayed uniform GFP expression throughout the body, with few uneven myotome GFP stripes at 3 dpf (Cat. IV). Also shown are 3 dpf
injected fish somites at higher magnification, demonstrating the difference in uniformity of GFP signals in tissues from various injection categories.
Injection GFP pattern distribution from typical RNA or protein mediated injection was shown. d GFP-positive F1 fish from either founder family
generated by mRNA injection or His-Tol2 injection were subjected to fin-clip and Southern blot analysis with a GFP probe. Each lane represents one
individual F1 adult fish. Southern blots from 5 adult fish selected from random founder family are shown for each method. See also Additional file 1
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minimal GFP signals, usually only a couple of bright
stripes in the myotomes; a category II pattern is character-
ized by large areas of the fish body with GFP signals, but
with little or no GFP-positive signals in the eyes or brain
region; and a category III pattern is characterized by whole
body green fluorescence, including the brain and eyes
(Fig. 3b).
Background, non-transposase mediated gene transfer
was measured by the injection of the RP2 vector without
transposase, resulting in sporadic GFP signals seen in
myotomal tissues of some F0 fish by 3 dpf. Usually, the
majority of the background GFP-positive fish displayed
category I patterns, and very few displayed category II
patterns (Fig. 3b).
When transposase was provided by Tol2 mRNA, the
overall somatic GFP signals were notably increased, es-
pecially with a higher number of embryos exhibiting the
category III pattern, which was a very rare observation
without the co-addition of transposase (Fig. 3b, c).
With His-Tol2 protein, the majority of the injected fish
did not display any GFP signal. Among the GFP-positive
F0 embryos, GFP patterns representing all three categor-
ies were noted. However, the number of category I ani-
mals, which were less likely to carry transposon-
mediated germ-line integration, was much lower than
the GFP-positive category II or category III (Fig. 3b, c).
We also conducted multi-generational testing for germ-
line gene transfer rate testing. F0 fish displaying category
III somatic patterning from either mRNA or His-Tol2
transposase resulted in a similar gene trapping rate and
low mosaicism (Table 1).
Interestingly, an additional pattern found only in
protein-injected embryos was observed. A small portion
of these injected animals (~5–10 %) exhibited ubiquitous
GFP expression as early as 24 h after injection (Fig. 3c),
and the signals were very uniform throughout the body
at 3 dpf (Fig. 3c). Such F0 embryos were designated cat-
egory IV (Table 1). Zebrafish embryos undergo rapid cell
divisions every 20 min during the early development and
reach ~ 1000 cells by 3 h post fertilization [29]. Thus the
timing of transposition potentially plays a critical role in
determining the mosaicism of resulting animals. We hy-
pothesized that the uniform GFP signals of the category
IV fish could be the result of very early integrations of
the GFP reporter gene into the genome. Indeed, a higher
percentage of germline transmission was obtained from
such F0 fish (Table 1). More importantly, the average F0
germline mosaicism was much reduced for category IV
fish (Table 1). Our observations of His-Tol2 mediated in-
jection suggest that even though transposition events
were rarer under current condition than when compared
to mRNA as a source of transposase, protein injection
can “jump start” integration inside the early zebrafish
embryo.
An important additional measurement of the germline
gene transfer rate is copy number. Transposon copy
number was estimated by Southern blot analysis on indi-
vidual fish (Fig. 3d). An average of ~ 4 unique trans-
poson insertions per haploid F0 founder germline were
observed (Additional file 1). The fact that category IV
(Additional file 1, family 1,2,3,5,6 and 8) did not contain
more transposon insertions than in other groups sug-
gests that the uniform fluorescence is most likely due to
earlier incorporation of the reporter gene into the
embryo genome.
Transposase-mediated insertion can be distinguished
from other insertion mechanisms by the target site
duplications flanking the transposon sequences. We
sequenced the insertion sites of the His-Tol2 protein-
mediated RP2 transposon insertions, and the hAT sig-
nature 8-bp genomic duplications were present in all
checked cases (Table 2). We conclude that His-Tol2 pro-
tein is a fully functional hAT transposase in both somatic
and germline lineages in vivo.
Recombinant Tol2 protein can mediate concerted target
joining in vitro
We continued to explore whether this recombinant Tol2
protein is functional in vitro, focusing on the target join-
ing step by directly assaying the ability of His-Tol2 to
join both ends of a DNA segment flanked by Tol2 end
sequences to a target plasmid (Fig. 4a). Tol2 terminal
sequences consisting of 261 bp from the left arm and
192 bp from the right arm (miniTol2) are sufficient
transposon end sequences for efficient Tol2 transpos-
ition in vivo [13, 14]. We used a PCR-generated KanR
gene flanked by these Tol2 ends (Additional file 2), mini-
Tol2-KanR together with His-Tol2 protein to assess tar-
get joining in vitro. After incubation of blunt end
miniTol2-KanR with an ampicillin resistant target plas-
mid (pGL) in the presence of His-Tol2 protein and Mn2+
ions, DNA was precipitated, transformed into E. coli,
Table 1 His-Tol2 and Tol2 mRNA as sources of transposase in
vivo






Cat II. mRNA 65 % (13/20) 27 %
Cat III. mRNA 88 % (35/40) 39 %
Cat III. Protein 76 % (13/17) 39 %
Cat IV. Protein 90 % (9/10) 51 %
Analyses of somatic and germline transmission of reporter genes are shown.
Fish injected with either mRNA or His-Tol2 were characterized by different F0
somatic patterns and assessed for corresponding germline trapping frequency,
estimated as the percentage of F0 fish producing GFP-positive offspring. The
number of fish screened is shown in parentheses. The F0 germline mosaicism
rate was determined by the percentage of GFP-positive F1 offspring from a
founder outcross. The average mosaicism rate for founder fish is listed from
each different category
Ni et al. Mobile DNA  (2016) 7:6 Page 6 of 11
and plated on LB-Amp+ plates to determine the total
number of target plasmids and on LB-Kan+ plates to
identify integration products (Fig. 4a, b). The number of
Tol2 integrants increased as the number of transposons
in the reaction increased (Fig. 4c, Additional file 3), and
we detected up to 0.8 % of integration ratio among the
conditions tested. We sequenced large numbers of inte-
grants obtained in multiple experiments and found that
the 8-bp host duplications at the insertion site characteris-
tic of hAT transposition occurred in 86 % of insertions
Table 2 Transposase-mediated germline integration
Site Sequence Chr. Refseq
1 aaatatttaccaagcaac-5′-Tol2-3′-caagcaacacgttcagtg 8 Intron of gfra2
2 ataatttcctcttatttg-5′-Tol2-3′-cttatttgcatgtcagat 13 Intergenic
3 cgcatgctaacttataga-5′-Tol2-3′-cttatagaggaggtgccc 8 Exon of wu: fb79a07
4 aaacgttcctcctaacac-5′-Tol2-3′-cctaacacagttagatgg 3 Intergenic
5 caacacatgactcgttgg-5′-Tol2-3′-ctcgttggccatatgcta 15 Intergenic
6 gggaatatgtgttattaa-5′-Tol2-3′-gttattaactgcgtccca 4 Repetitive sequences
7 agctgtctcttctgtgtc-5′-Tol2-3′-tctgtgtcattcagtctc 3 Intron of LOC557901
8 tgtcagagatctaggtca-5′-Tol2-3′-ctaggtcagatggaggaa 25 Intergenic
Tol2 insertion sites generated by His-Tol2 protein co-injection were cloned from F1 transgenic fish. Examples of 8-bp genomic sequence duplication (in bold) were
shown with insertion loci information
C
D
Fig. 4 Tol2 in vitro integration assay. a Scheme of in vitro integration assay. b One example miniTol2-KanR integration, revealing different
kanamycin-resistant colony recovery from assays with versus without His-Tol2 protein. The amount of transformed bacteria spread on each plate is
indicated. c Tol2-mediated miniTol2-KanR integration. The amount of target plasmid (pGL) was kept at 0.5 pMol, while PCR fragments were mixed at
three different ratios. The ratio of colony numbers (Additional file 3) recovered from LB-Kan+ to LB-Amp+ was used as an indicator of integration
activity. Bars represent mean values ± SEM from three independent experiments. d Plasmids isolated from colonies on LB-Kan+ plate were sequenced
at both junctions of miniTol2-KanR insertion. 8-bp target plasmid duplications were indicated. Six examples of the integration junction are shown here
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(Total N = 333) (Fig. 4d). Thus His-Tol2 integration in vitro
recapitulates Tol2 integration in vivo. The distribution of
recovered insertions in the target plasmid was non-
random with miniTol2 element insertion biased towards
the AT-rich (AT content 64 %) SV40 polyA segment of
the target vector (Fig. 5a; see also below). We also noticed
that Tol2 protein was able to excise a miniTol2-flanking
fragment out of a plasmid donor (data not shown), indi-
cating His-Tol2 is fully competent gene transfer vector in
vitro as well as in vivo.
Target site preference of Tol2 is conserved using a
simplified target plasmid system
As described above, the miniTol2-KanR-insertions gener-
ated in vitro were not randomly distributed on the target
plasmid, and they clustered at the SV40 poly (A) rich re-
gion. Analysis of these patterns by Monte Carlo simula-
tion demonstrated that the bias was highly significant
(p-value by simulation < 0.0001, see Methods) in each of
four independent experiments (Fig. 5a; Additional file 4
and Additional file 5). This observed preference in vitro is
in agreement with prior work showing that Tol2 has a pref-
erence for AT-rich regions in vivo.More importantly, the in
vivo observed integration signature, TNA(C/G)TTA-
TAA(G/C)TNA (bold: insertion site) [12], was similar to
the findings reported here using the plasmid insertion
system (Fig. 5b). This observation suggests a primary
sequence of the target site is likely to play a critical
role in Tol2/hAT integration site selection.
Discussion
In the past decade, the Tol2-based transposition system
has become a versatile tool for gene delivery in com-
monly used model organisms, especially in zebrafish,
which has seen many cases of successful genetic screen-
ing with various highly efficient Tol2 systems [30, 31].
Recently, Tol2 transposon tools have been applied to
pioneer gene transfer in novel biological systems, such
as haplochromine cichlid [32, 33] and African killifish
[33]; or as an alternative to viral vectors showing prom-
ise in engineered T-cell therapy [34]. Here we report the
purification of recombinant Tol2 hAT transposase from
A
B
Fig. 5 miniTol2 insertion sites and consensus sequence. a Tol2-mediated insertions from four independent experiments were mapped to target
plasmid (pGL) for miniTol2-KanR (n = 266). Y-axis indicates the number of insertion events and orientation (positive: sense orientation; negative:
anti-sense orientation) Major features of the pGL vector were also indicated. Red lines below the sequences indicate insertion “hot spots”, defined
as the same locations that are discovered in more than one experiment, regardless of the insertion orientation or locations in one experiment that
have transposons inserted in both directions (also see Additional file 5). b Tol2 integration site motif analyzed by WebLog (version 3.0) (n = 266) and
aligned to a previous indentified weak AT-rich consensus in vivo [12]
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E. coli and demonstrate that it is fully functional in vivo
and in vitro. A functional recombinant Tol2 protein will
be a useful addition to the Tol2-based genome engineer-
ing kit. Researchers will have more choices over what
form of transposase will work best for the organisms/
cells of their interest. Transposase provided as readily
made protein, in some systems, may be advantageous
over an mRNA-based delivery method. For example,
when the translation of the Tol2 mRNA is not efficient
or optimized for the intended heterologous system. And
even in zebrafish where mRNA is an effective method
for Tol2 delivery, we noted advantages of using the func-
tional Tol2 transposase protein.
We observed robust somatic and germline transposition
in zebrafish using E.coli -purified Tol2 transposase. Our
experiments suggest using His-Tol2 may be advantageous
in generating low mosaic transgenic animals with higher
germline transmission rate. Transposition using a protein
source of transposase may “jumpstart” transposition as it
avoids possible delays from transcription, translation and
assembly of a functional transpososome containing trans-
posase multimers when transposase is supplied in a ready
form. Transposase multimers are the active form of trans-
posase in other studied systems [7, 35, 36]. Static light
scattering analysis has shown that purified Tol2 is a dimer
(A. Voth and F. Dyda, personal communication). This
recombinant Tol2 protein is an excellent tool for future
experimental methods for gene delivery. As documented
using this initial system, the percentage of GFP-positive
F0 embryos was lower using protein as a transposase
source when compared to the well-established mRNA co-
injection methods,. However, the current protein co-
injection method has yet to be fully optimized, such as
experimentally establishing the optimal protein to donor
plasmid ratio.
Functional Tol2 transposase protein is also of use for
studying transposon biology science, enabling experi-
mental testing of this hAT element both in vivo and in
vitro. Such work will shed more light on our under-
standing of how this and related transposons work in
the future. In this paper, we demonstrated that Tol2 pro-
tein could be used in an assay to probe the integration
site preference for the transposon and identified a weak
consensus that are largely conserved between in vivo
chromosomes and a cell-free target plasmid. Two other
commonly used transposases for genome engineering,
Sleeping Beauty and piggyBac use obligate TA and
TTAA core consensus targeting sequence respectively
[37, 38]. In contrast, Tol2 target site selection is still con-
sidered promiscuous on the level of primary DNA se-
quence [39]. The preference noticed towards AT-rich
DNA context could also reflect a preference towards
integration into regions of higher DNA flexiblity as
suggested previously [40–42].
Conclusions
We presented here a fully functional recombinant trans-
posase protein, both in vitro and in vivo, for the popular
vertebrate gene transfer transposon Tol2. Our initial
work in zebrafish indicated that His-Tol2 has a high po-
tential for genome engineering applications. His-Tol2
can also serve as a tool for probing transposon biology
in vitro and help confirm an integration site consensus
shared between in vivo and cell-free systems.
Methods
Ethics statement
Zebrafish larvae were raised within the Mayo Clinic’s
Zebrafish Facility with adherence to the NIH Guide for the
Care and Use of Laboratory Animals and approval by Mayo
Clinic’s Institutional Animal Care and Use Committee.
Important constructs
Details of how important constructs were made are in-
cluded in Additional file 6: Supplemental Experimental
Procedures.
HeLa cell transfection assays
Transfection of HeLa cells with a Zeocin resistant vector
(pTol2miniZeo) with either control vector pCMV-GFP
or vectors providing Tol2 transposase (pCMV-Tol2-M,
pCMV-hTol2-M or pCMV-hTol2-L) was following the
same protocol as described in [21]. Zeocin-resistant col-
ony forming assay was conducted as in [21] as well.
Zebrafish somatic transposition assays
To compare transposition of a GFP-reporter mediated
by tagged vs. untagged Tol2 mRNA (Fig. 1d), zebrafish
embryos were injected at one-cell stage with a mixture
of 25 pg pTol2-S2EF1α-GM2 (pDB591, [13]) plasmid
DNA with 25 pg or 100 pg T3TS-Tol2-M (Tol2), T3TS-
His-Tol2, or T3TS-His-Tol2 RNA (Fig. 1d) respectively.
Surviving normal-looking embryos were scored for GFP
fluorescence at 3 dpf.
Protein expression and immunoblotting
Small scale detection of protein expression was conducted
according to Qiagen recommended protocol. Detail pro-
cedures are included in Additional file 6: Supplemental
Experimental Procedures. His-Tol2 protein expression was
detected by penta-His antibody (Qiagen) following the rec-
ommended western protocol. An adapted protocol [43] was
used to generate large-scale nuclease-free protein fractions.
Zebrafish one-cell GBT microinjection
One-cell stage zebrafish microinjection was performed as
described [44]. The injected amount of reagents were 25 pg
GBT-RP2 plasmid co-injected with 25 pg T3TS-Tol2
mRNA [13]; or co-injected with ~ 0.2 ng His-Tol2 protein.
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Southern blot
Genomic DNA isolation and Southern blot hybridization
was conducted as previously described [28]. Tail fins
from individual GFP-positive F1 fish generated by co-
injection of Tol2 mRNA or His-Tol2 protein at F0 were
clipped and genomic DNA was isolated followed by
digestion with BamHI and BglII for Southern blotting.
Molecular analysis of genomic integration sites
Cloning of insertion site in F1 individual fish was con-
ducted through adapted inverse and linker-mediated
PCR (LM-PCR) [44]. Information of primer sequences
and PCR conditions are included in Additional file 6:
Supplemental Experimental Procedures.
In vitro integration assay
Blunt end miniTol2-KanR fragments were generated by
PCR with platinum Pfx DNA polymerase (Invitrogen) with
forward primer Tol2-mini5′ (5′- CAGAGGTGTAAAGT
ACTTGA-3′), reverse primer Tol2-mini3′ (5′- CAG
AGGTGTAAAAAGTACTC-3′) and a template (pTol2mi-
niKan(-)amp). PCR product was treated with DpnI to get
rid of the template before purified by QIAquick PCR puri-
fication kit (Qiagen). Freshly prepared plasmids and PCR
products were used in the assay. In a 20 μL reaction, 0.5
pMol plasmid pGL, corresponding PCR fragments and 27
pMol His-Tol2 (~2 μg) were mixed in MOPS buffer
(25 mM MOPS, pH 7.0; 1 mM MnCl2; 50 mM NaCl; 5 %
glycerol; 2 mM DTT; 100 ng/ul BSA). The reaction was in-
cubated for 2 h at 30 °C. DNA was phenol-chloroform ex-
tracted using Maxtract High Density columns (Qiagen)
and resuspended in 5 μL TE buffer. 1 μL or 5 μL DNA was
used to transform Top10 competent cells (Invitrogen). The
number of colonies grew on Amp-resistant plates was used
to calculate the total number recovered plasmids, and the
number of colonies that grew on Kan-resistant plates was
used to calculate the number of plasmid with KanR integra-
tion. MOPS buffer with MgCl2 or no added cations were
tested as well, and the integration activity was modestly
higher with MnCl2.
Insertion site distribution statistics
The simulation distributions of the number of insertions
over the target features was done in R. We assume that
every feature gets a number of distributions proportional
to its size in bp. We simulated 75 counts with the prob-
ability of a count falling into a feature being the length of
that feature divided by the length of all features types. We
then ran this simulation 10,000 times. To check where the
experimental data lie with respect to the simulated data,
we determined how often the simulated counts are bigger
or smaller than the experimental data.
Additional files
Additional file 1: Estimation of transposon insertion numbers by
Southern analysis. Individual GFP-positive F1 fish from random selected
F0 founder families were fin-clipped for gDNA isolation. Southern blotting
with a GFP probe was conducted for each fish gDNA and the number of
clear-labeled Southern bands was recorded as estimation of transposon
insertions. Total number of unique Southern bands was used to estimate
total transposon insertions for each F0 founder family. An average insertion
number over all the families analyzed was calculated for both injection
methods. (DOCX 91 kb)
Additional file 2: miniTol2 sequences of the in vitro assays. DNA
sequences of the left arm and right arm of miniTol2 flanking the KanR
used in the in vitro integration assays. (DOCX 55 kb)
Additional file 3: Colony counting numbers for in vitro integration
assays. Colony numbers counted for the three independent experiments
in Fig. 4c of different target plasmid and PCR insert ratios. (DOCX 49 kb)
Additional file 4: P-value by simulation. For each independent repeat of
miniTol2 mediated KanR insertion distribution, p-value was generated by
simulation (see Methods) for different features on the target plasmid.
(DOCX 61 kb)
Additional file 5: Insertion “hot spots” for miniTol2. “Hot spots” were
arranged according to the insertion loci along the target plasmid. 8-bp
target duplication and flanking sequnces were shown. Forward (F) or
reverse (R) insertion copies were counted. Repeats coverage indicate the
“hot spot” indentified by how many independent experiments. (XLSX 45 kb)
Additional file 6: Supplemental Experimental Procedures. (DOCX 131 kb)
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